S134N copper-zinc superoxide dismutase (SOD1) is one of the many mutant SOD1 proteins known to cause familial amyotrophic lateral sclerosis. Earlier studies demonstrated that partially metaldeficient S134N SOD1 crystallized in filament-like arrays with abnormal contacts between the individual protein molecules. Because protein aggregation is implicated in SOD1-linked familial amyotrophic lateral sclerosis, abnormal intermolecular interactions between mutant SOD1 proteins could be relevant to the mechanism of pathogenesis in the disease. We have therefore applied NMR methods to ascertain whether abnormal contacts also form between S134N SOD1 molecules in solution and whether Cys-6 or Cys-111 plays any role in the aggregation. Our studies demonstrate that the behavior of fully metallated S134N SOD1 is dramatically different from that of fully metallated wild type SOD1 with a region of subnanosecond mobility located close to the site of the mutation. Such a high degree of mobility is usually seen only in the apo form of wild type SOD1, because binding of zinc to the zinc site normally immobilizes that region. In addition, concentration-dependent chemical shift differences were observed for S134N SOD1 that were not observed for wild type SOD1, indicative of abnormal intermolecular contacts in solution. We have here also established that the two free cysteines (6 and 111) do not play a role in this behavior.Over 100 different mutations in the superoxide dismutase 1(SOD1) 4 gene have been linked to the inherited form of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease characterized by progressive death of motor neurons and consequent paralysis. The individual mutations have been shown to exert their pathological effects by a gain of function mechanism, implying that the copper-zinc superoxide dismutase variant (Cu,Zn-SOD) expressed from the mutated gene has in some way become toxic. Recent evidence suggests that SOD1-linked ALS, like many other neurodegenerative diseases, is a protein misfolding disorder characterized by abnormal deposits of aggregated proteins in neural tissues (1-3). Implicated also in the toxicity of ALS-mutant SOD1 proteins are accelerated oxidative damage and inhibition of proteasome, chaperone, or mitochondrial function (2, 4, 5).Relatively large, insoluble proteinaceous inclusions are observed in neural tissue in ALS and other neurodegenerative diseases, but it has been proposed that, rather than causing the disease, these deposits of aggregated protein may be formed as a part of a defensive mechanism to sequester misfolded and oligomerized protein when excessive amounts accumulate. More recently it has been suggested that the toxic species are smaller, high molecular weight oligomerized proteins formed from abnormal contacts of misfolded proteins resulting in protofibrils, pores, or other toxic species (6 -10). High molecular weight forms of oligomerized mutant SOD1 have been observed in several studies using ALS-SOD1 transgenic mice (11-13).Many of the ALS-linked Cu,Zn-S...